Nigel Crossland takes a deep dive into the world of pharmaceutical development and quality assurance.
It would be unreasonable to think that patients should be expected to agree to the taking of drugs if there was no proof of their effectiveness or relative safety. The idea of taking drugs merely on unsubstantiated trust belongs to the past and is not acceptable in the modern age of scientific evaluation. As pharmaceutical products are manufactured, licensed, sold, prescribed and used worldwide it is essential that evidence of quality, efficacy and safety are proven, and supportive documentation is made available to the respective national regulatory authorities for approval and licensing purposes.
Click here to read the full article.
Image credit | iStock